{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:00:27Z","timestamp":1781053227243,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.steroids.2026.109797","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:16:00Z","timestamp":1778451360000},"page":"109797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of serum Afamin and oxidative stress biomarkers in polycystic ovarian syndrome overweight women"],"prefix":"10.1016","volume":"231-232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7543-6069","authenticated-orcid":false,"given":"Sara Sardar","family":"Hamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardar Nouri","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.steroids.2026.109797_b0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/life12020225","article-title":"Assessment of the parameters of oxidative stress depending on the metabolic and anthropometric status indicators in women with PCOS","volume":"12","author":"Nawrocka-Rutkowska","year":"2022","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.steroids.2026.109797_b0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/antiox12030730","article-title":"Antioxidant defense expressed as glutathione status and Keap1-Nrf2 system action in relation to anthropometric parameters and body composition in young women with polycystic ovary syndrome","volume":"12","author":"Che\u0142chowska","year":"2023","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.steroids.2026.109797_b0015","article-title":"A Review of Afamin as Metabolic Novel Marker of many Diseases","volume":"2","author":"Abed","year":"2023","journal-title":"Wasit J Pure Sci"},{"key":"10.1016\/j.steroids.2026.109797_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.670425","article-title":"Serum afamin a novel marker of increased hepatic lipid content","volume":"12","author":"Kurdiova","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.steroids.2026.109797_b0025","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1007\/s00210-024-03745-w","article-title":"Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research","volume":"398","author":"Yazdanpanah","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.steroids.2026.109797_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5455\/jabet.2023.d102","article-title":"Oxidant and antioxidant status of erythrocytes and plasma samples in polycystic ovary syndrome patients","volume":"6","author":"Nawar","year":"2022","journal-title":"Journal of Advanced Biotechnology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.steroids.2026.109797_b0035","first-page":"486","article-title":"Comparison of serum oxidative stress markers of malondialdehyde and total antioxidant capacity between women with infertility due to polycystic ovary syndrome and tubal factor","volume":"5","author":"Egeonu","year":"2023","journal-title":"Int Gyn & Women\u2019s Health"},{"issue":"4","key":"10.1016\/j.steroids.2026.109797_b0040","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/jmv.26725","article-title":"Evaluation of maternal serum afamin and vitamin E levels in pregnant women with COVID\u201019 and its association with composite adverse perinatal outcomes","volume":"93","author":"Erol","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.steroids.2026.109797_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1157114","article-title":"Serum afamin levels in predicting gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.steroids.2026.109797_b0050","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J. Assist. Reprod. Genet."},{"issue":"3","key":"10.1016\/j.steroids.2026.109797_b0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum. Reprod. Update"},{"issue":"3","key":"10.1016\/j.steroids.2026.109797_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.18502\/ijrm.v20i3.10707","article-title":"Assessment of metabolic syndrome in infertile women with polycystic ovary syndrome in a rural population of South India: a cross-sectional study","volume":"20","author":"Kayali","year":"2022","journal-title":"Int. J. Reprod. BioMed."},{"issue":"2","key":"10.1016\/j.steroids.2026.109797_b0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/humrep\/dew287","article-title":"The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?","volume":"32","author":"Wang","year":"2017","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.steroids.2026.109797_b0070","first-page":"256","article-title":"Estimation of Atherogenic Index of Plasma, Prolactin, and some Other Hormones in Polycystic Ovarian Syndrome in Lean Women","volume":"13","author":"Hamad","year":"2025","journal-title":"Aro-Sci. J. Koya Univ."},{"issue":"1","key":"10.1016\/j.steroids.2026.109797_b0075","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4579831","article-title":"Role of oxidative stress in obese and nonobese PCOS patients","volume":"2022","author":"U\u00e7kan","year":"2022","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.steroids.2026.109797_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"Journal of Ovarian Research"},{"issue":"5","key":"10.1016\/j.steroids.2026.109797_b0085","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/humrep\/deae050","article-title":"Evolution of evidence-based diagnostic criteria in adolescents with polycystic ovary syndrome","volume":"39","author":"Teede","year":"2024","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.steroids.2026.109797_b0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1477-7827-12-88","article-title":"Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome","volume":"12","author":"Seeber","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.steroids.2026.109797_b0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2015.04.010","article-title":"Afamin\u2014a pleiotropic glycoprotein involved in various disease states","volume":"446","author":"Dieplinger","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.steroids.2026.109797_b0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.steroids.2026.109797_b0105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41443-023-00717-1","article-title":"Hyperprolactinemia and male sexual function: focus on erectile dysfunction and sexual desire","volume":"36","author":"Corona","year":"2024","journal-title":"Int J Impot Res"},{"issue":"6","key":"10.1016\/j.steroids.2026.109797_b0110","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1007\/s12010-023-04710-8","article-title":"Insights into vitamin E with combined oral contraceptive on INSR gene in PCOS by integrating in silico and in vivo approaches","volume":"196","author":"Begum","year":"2024","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.steroids.2026.109797_b0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00380-020-01663-4","article-title":"Clinical impact of admission urinary 8-hydroxydeoxyguanosine level for predicting cardiovascular mortality in patients with acute coronary syndrome","volume":"36","author":"Gohbara","year":"2021","journal-title":"Heart Vessels"},{"issue":"16","key":"10.1016\/j.steroids.2026.109797_b0120","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.3390\/ijms25169037","article-title":"The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: a molecular and cellular review of the literature","volume":"25","author":"Chang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.steroids.2026.109797_b0125","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil. Steril."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X26000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X26000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:38:34Z","timestamp":1781051914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X26000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S0039128X26000590"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2026.109797","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of serum Afamin and oxidative stress biomarkers in polycystic ovarian syndrome overweight women","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2026.109797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109797"}}